Standard Neutrophil-to-Lymphocyte Percentage and Glasgow Prognostic Rating are generally Connected with Medical End result throughout Individuals with Recurrent or Metastatic Head and Neck Squamous Mobile Carcinoma Addressed with Nivolumab.